BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29316310)

  • 1. MELD as a metric for survival benefit of liver transplantation.
    Luo X; Leanza J; Massie AB; Garonzik-Wang JM; Haugen CE; Gentry SE; Ottmann SE; Segev DL
    Am J Transplant; 2018 May; 18(5):1231-1237. PubMed ID: 29316310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.
    Atiemo K; Skaro A; Maddur H; Zhao L; Montag S; VanWagner L; Goel S; Kho A; Ho B; Kang R; Holl JL; Abecassis MM; Levitsky J; Ladner DP
    Am J Transplant; 2017 Sep; 17(9):2410-2419. PubMed ID: 28226199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival benefit of accepting livers from deceased donors over 70 years old.
    Haugen CE; Bowring MG; Holscher CM; Jackson KR; Garonzik-Wang J; Cameron AM; Philosophe B; McAdams-DeMarco M; Segev DL
    Am J Transplant; 2019 Jul; 19(7):2020-2028. PubMed ID: 30614634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The decreasing predictive power of MELD in an era of changing etiology of liver disease.
    Godfrey EL; Malik TH; Lai JC; Mindikoglu AL; Galván NTN; Cotton RT; O'Mahony CA; Goss JA; Rana A
    Am J Transplant; 2019 Dec; 19(12):3299-3307. PubMed ID: 31394020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
    Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
    Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of whole-organ in lieu of split-liver transplantation over the last decade: Children experienced increased wait time and death.
    Valentino PL; Emre S; Geliang G; Li L; Deng Y; Mulligan D; Rodriguez-Davalos MI
    Am J Transplant; 2019 Nov; 19(11):3114-3123. PubMed ID: 31152483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
    Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
    Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum sodium and survival benefit of liver transplantation.
    Sharma P; Schaubel DE; Goodrich NP; Merion RM
    Liver Transpl; 2015 Mar; 21(3):308-13. PubMed ID: 25504743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pretransplant serum creatinine on the survival benefit of liver transplantation.
    Sharma P; Schaubel DE; Guidinger MK; Merion RM
    Liver Transpl; 2009 Dec; 15(12):1808-13. PubMed ID: 19938142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
    Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
    Ravaioli M; Lai Q; Sessa M; Ghinolfi D; Fallani G; Patrono D; Di Sandro S; Avolio A; Odaldi F; Bronzoni J; Tandoi F; De Carlis R; Pascale MM; Mennini G; Germinario G; Rossi M; Agnes S; De Carlis L; Cescon M; Romagnoli R; De Simone P
    J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCC patients suffer less from geographic differences in organ availability.
    Schuetz C; Dong N; Smoot E; Elias N; Schoenfeld DA; Markmann JF; Yeh H
    Am J Transplant; 2013 Nov; 13(11):2989-95. PubMed ID: 24011291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.
    Sharma P; Schaubel DE; Messersmith EE; Guidinger MK; Merion RM
    Liver Transpl; 2012 Dec; 18(12):1456-63. PubMed ID: 22965903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
    Francoz C; Belghiti J; Castaing D; Chazouillères O; Duclos-Vallée JC; Duvoux C; Lerut J; Le Treut YP; Moreau R; Mandot A; Pageaux G; Samuel D; Thabut D; Valla D; Durand F
    Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
    da Silva Machado AG; de Medeiros Fleck A; Marroni C; Zanotelli ML; Cantisani G; de Mello Brandão AB
    Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Outcomes of Liver Transplantation for Model for End-Stage Liver Disease Score ≥40: The Impact of Share 35.
    Nekrasov V; Matsuoka L; Rauf M; Kaur N; Cao S; Groshen S; Alexopoulos SP
    Am J Transplant; 2016 Oct; 16(10):2912-2924. PubMed ID: 27063579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.